User-defined outline with 11 sections.

Executive Summary

ZimAgri Biotech (Pvt) Ltd is building a profitable Zimbabwean crop diagnostics and bio-input business

ZimAgri Biotech (Pvt) Ltd is a Harare-based private limited company focused on affordable, rapid crop diagnostics and microbial biofertilisers for smallholder and emerging commercial farmers across Zimbabwe. We solve a costly production problem: farmers are still making fertiliser and disease-control decisions without timely, locally relevant data, which leads to wasted input spend, delayed interventions, and lower yields.

Our model combines soil test kits, disease test strips, microbial biofertiliser, and seasonal advisory packages into one commercially coherent offer. We sell directly to farmers, through agrodealers, and through NGO and extension-linked channels, giving us both transactional revenue and recurring seasonal income.

The business is led by the founder and CEO, who has a background in agricultural biotechnology and field research in Zimbabwe. The wider team gives us the technical, financial, and commercial depth to execute from launch: Alex Chen, our part-time CFO and chartered accountant with 10 years of SME and agribusiness finance experience in Southern Africa; Avery Singh, our lead agronomist with an MSc in Agronomy and 8 years of experience in seed and fertiliser companies across Mashonaland; Taylor Nguyen, our lab and quality manager and microbiologist with 6 years in controlled bio-input production and food safety labs; and Dakota Reyes, our marketing and digital lead with 7 years of experience in social media campaigns and rural radio marketing for agriculture and FMCG brands in Zimbabwe.

The market opportunity is immediate and repeatable

Zimbabwe’s farming base needs faster diagnostics, lower-cost biological inputs, and practical agronomy support that can be used in the same season. Our reachable market includes at least 40,000 smallholder and emerging commercial farms in the Mashonaland and Manicaland corridors, plus agrodealers and climate-smart agriculture programmes that need measurable farmer outcomes.

We are positioned for repeat demand because our products fit recurring decision points before planting, during crop stress, and when disease symptoms appear. That creates seasonal purchase cycles and strong customer lifetime value, not just one-off sales.

:::reassure
Why the opportunity is commercially strong

• Farmers need fast answers, not delayed lab reports.
• Our products are affordable enough for repeat use.
• Agrodealers and NGOs expand reach without heavy fixed infrastructure.
  :::

Our financial outlook is already modeled for early profitability

The financial model shows Year 1 revenue of USD 144,000, rising to USD 172,800 in Year 2, USD 193,536 in Year 3, USD 209,019 in Year 4, and USD 219,470 in Year 5. Gross margin holds at 68.0% across the forecast period, which gives the business room to scale while maintaining strong unit economics.

Break-even is achieved at USD 132,132 in annual revenue, and the model indicates break-even timing in Month 1 within Year 1. That means the business clears its fixed-cost base early and moves into positive cash generation from launch.

Capital request and use of funds

We are seeking USD 60,000 in total funding to complete our launch and working-capital needs. The structure is USD 10,000 in founder equity and USD 50,000 in long-term debt, with funds allocated to the Harare lab and packaging base, initial operating expenses, and working capital for raw materials and market expansion.

The capital structure is disciplined and sized to match our forecast. It allows us to launch without overbuilding infrastructure, while still supporting the product quality, delivery speed, and marketing intensity needed to win customers in Zimbabwe’s agricultural market.

:::tip
Funding logic in one line
We are raising enough capital to launch cleanly, trade through the early ramp-up, and reach a revenue base that can service debt and support reinvestment.
:::

At a glance

• Business: ZimAgri Biotech (Pvt) Ltd
• Location: Harare, Zimbabwe
• Structure: Private limited company
• Core offer: Soil diagnostics, disease diagnostics, microbial biofertiliser, and advisory packages
• Year 1 revenue: USD 144,000
• Year 3 revenue: USD 193,536
• Year 5 revenue: USD 219,470
• Gross margin: 68.0%
• Break-even revenue: USD 132,132
• Break-even timing: Month 1 within Year 1
• Total funding required: USD 60,000

Our revenue mix is also balanced enough to reduce dependency on any single product line. In Year 1, biofertiliser contributes USD 63,000, soil test kits contribute USD 36,000, advisory packages contribute USD 30,600, and disease test strips contribute USD 14,400. That mix supports both product-led growth and service-led retention.

The business is designed for investors and lenders who want a focused Zimbabwean agribiotech company with realistic economics, clear customer demand, and disciplined execution. ZimAgri Biotech is not a speculative concept; it is a lean, revenue-generating farming solutions business with strong margins, early break-even, and a growth path that remains grounded in the realities of Zimbabwean agriculture.

Company Description

ZimAgri Biotech (Pvt) Ltd

ZimAgri Biotech (Pvt) Ltd is a Zimbabwe-registered private limited company based in Harare, positioned to serve farmers and agricultural value-chain partners across the country’s key cropping regions. We operate from a compact lab and office location near the main agriculture supply corridor, which gives us practical access to Mashonaland East, Mashonaland West, Mashonaland Central, and the wider Harare agro-input network.

We founded ZimAgri Biotech to solve a commercial problem that affects farm productivity every season: farmers are making high-stakes input decisions without fast, affordable, and locally relevant diagnostic support. Our business is built around rapid crop diagnostics and biofertiliser products that help smallholder and emerging commercial farmers protect yield, improve soil health, and reduce wasteful spending on imported chemicals.

What We Do and Who We Serve

Our core customers are smallholder and emerging commercial farmers in Zimbabwe, especially those farming 2 to 50 hectares in Mashonaland and Manicaland. These farmers are typically managing maize, soyabeans, tobacco, horticulture, and other mixed cropping systems, and they need practical answers on soil fertility, plant stress, and disease pressure before they buy or apply expensive inputs.

We sell three linked offerings:

• Rapid soil test kits that help farmers understand nutrient status and make better fertiliser decisions.
• Crop disease diagnostic strips that identify common plant health threats early enough to guide intervention.
• Microbial biofertiliser blends that support soil biology and improve nutrient availability using locally adapted strains.
• Seasonal advisory packages that translate test results into clear field action, application timing, and input guidance.

Our model is intentionally simple for adoption. Farmers and agrodealers can buy products directly, while advisory customers receive structured support over the season instead of one-off advice with no follow-through.

The Problem We Solve in Zimbabwean Agriculture

Zimbabwean crop producers face a costly information gap. Soil testing is often slow, centralised, or too expensive for routine use, while disease diagnosis is frequently delayed until visible damage has already reduced yield potential. At the same time, many farmers are paying for fertiliser and chemical inputs without the confidence that those products match actual field conditions.

ZimAgri Biotech closes that gap by bringing diagnostic capability closer to the farm gate. We combine affordable biotech tools with practical agronomic interpretation, so farmers do not just receive data, they receive a usable decision.

:::reassure Why our model fits the market

• Farmers want lower-risk input decisions, not laboratory jargon.
• Agrodealers want products that create repeat customer traffic and trust.
• NGOs and extension partners want tools that support climate-smart agriculture at scale.
  :::

Legal Structure, Ownership, and Governance

ZimAgri Biotech operates as a private limited company (Pvt Ltd) in Zimbabwe. This structure gives us a clear legal identity for investor participation, supplier contracts, product registration, and future expansion into regional markets.

Ownership is structured to preserve founder control while creating space for growth capital. The founder holds 70% equity, and the remaining 30% is reserved for an early technical co-founder and seed investors. The current capital stack reflects USD 10,000 in equity capital and USD 50,000 in debt principal, making total funding USD 60,000.

This structure supports disciplined scale-up without overextending the business early. It also allows us to fund lab buildout, early operations, and working capital while keeping the company investable for future rounds.

Founding Position and Mission

ZimAgri Biotech was established to become Zimbabwe’s practical crop diagnostics and bio-input company for farmers who need affordable, field-ready solutions. Our mission is to improve crop productivity and soil health through locally adapted biotechnology products, backed by advice that farmers can apply immediately.

We are not building a generic agronomy brand. We are building a Zimbabwe-specific biotech platform with products tested and positioned for local soils, local crops, and local farm economics.

Leadership and Operational Capability

The business is led by the founder and CEO, who has a background in agricultural biotechnology and field research in Zimbabwe. That technical base matters because our products depend on reliable formulation, testing, and farmer-facing interpretation.

The rest of the core team strengthens the business across finance, agronomy, quality, and market access:

• Alex Chen, our part-time CFO, is a chartered accountant with 10 years’ experience in SME and agribusiness finance in Southern Africa.
• Avery Singh, our lead agronomist, holds an MSc in Agronomy and has 8 years of experience working with seed and fertiliser companies across Mashonaland.
• Taylor Nguyen, our lab and quality manager, is a microbiologist with 6 years in quality-controlled production of bio-inputs and food safety laboratories.
• Dakota Reyes, our marketing and digital lead, brings 7 years of experience in social media campaigns and rural radio marketing for agriculture and FMCG brands in Zimbabwe.

This blend of technical and commercial capability gives ZimAgri Biotech the discipline to develop products, the agronomic depth to support farmers, and the market reach to turn diagnostics into recurring revenue.

Geographic Focus and Distribution Logic

Our near-term operating footprint is deliberately concentrated. We are prioritising Harare and the surrounding production corridor first, then expanding through agrodealers, extension networks, and field demonstrations into Mashonaland and Manicaland.

That geography is commercially attractive because it gives us access to a dense concentration of crop farmers and input distributors. It also shortens delivery times, reduces transport cost, and makes on-farm support practical.

Market Positioning

ZimAgri Biotech sits at the intersection of agricultural inputs, diagnostics, and advisory services. Our competitive advantage is not just product innovation, but the way we package that innovation for Zimbabwean farmers who need speed, affordability, and clear recommendations.

We differentiate ourselves through:

• Fast, on-site diagnostics instead of slow central lab workflows.
• Locally adapted biofertiliser strains rather than generic imported formulations.
• Actionable recommendations tied to soil and disease results.
• Transparent pricing and direct farmer support through mobile channels.
• Training days and agrodealer partnerships that build trust and repeat use.

:::tip How we keep the business investable
We have kept the operating model lean, the product mix focused, and the customer base specific. That gives ZimAgri Biotech a clear path from early adoption to repeat seasonal demand without depending on a single client or donor programme.
:::

Strategic Direction

Our first phase is focused on proving adoption among farmers who already feel the cost of poor soil decisions and delayed disease response. From there, we expect demand to expand through agrodealers, NGOs, and larger commercial growers who want dependable, local biotech support.

We are building ZimAgri Biotech as a long-term Zimbabwean agriculture company with room to scale into neighbouring markets later. The immediate priority is simple: give farmers better diagnostics, better bio-inputs, and better harvest decisions from a company that understands the reality of farming in Zimbabwe.

🔒 Continues in the full version

The remaining 9 sections of this document cover:

• Products and Services
• Market Analysis
• Competitive Analysis
• SWOT Analysis
• Marketing and Sales Strategy
• Management and Organization
• Operating Plan
• Financial Plan and Projections
• Funding Request

The full document is available below — click through for complete access.